Several mechanisms have been described for regulation of cytokine responses. Among these mechanisms are cytokine and cytokine receptor gene activation, binding to soluble receptors, receptor atangonists, interference with signal transduction, and functionally counteracting cytokines (1, 2, 9) . During bacterial challenges, different cytokines and inflammatory mediators are upregulated. They may play an important role in the control of infections, but produced in excess or at the wrong site, they can cause pathological changes (5) .
Haemophilus influenzae type b (Hib) is a major cause of bacterial meningitis, resulting in 1 million fatalities worldwide per year (18) . The experimental model usually used to study pathogenetic mechanisms and new treatment involves intracisternal inoculation of rats with Hib. This results in a disease with a fatal outcome within 48 h (17) . Intraperitoneal inoculation of 3-week-old Sprague-Dawley rats resulted in a nonfatal meningitis with high leukocyte counts (mean numbers of cerebrospinal fluid [CSF] cells from six rats were 2,495 at 48 h and 2,187 at 7 days postinoculation [p.i.]) and positive bacterial cultures in CSF in all animals examined. By in situ hybridization with labelled oligonucleotide probes, cytokine mRNAexpressing cells were detected early in CSF, the central nervous system, and lymphoid organs. In spleen, for example, all cytokines examined (interleukin-1 [IL-1], IL-4, IL-6, IL-10, IL-12, gamma interferon [IFN-␥], tumor necrosis factor alpha [TNF-␣], and transforming growth factor beta) were elevated at 12 h p.i. (7a). All of these cytokines expressed in this model may be implicated in various aspects of the sequential immunopathology. Elucidation of triggering events and mechanisms for control of these responses in order to minimize the profound effects on homeostasis of the immune system due to such changes in mediators is the goal of this study.
MATERIALS AND METHODS
The model for bacterial infection. Hib strain LCR 528, originally obtained from the CSF of a patient with H. influenzae meningitis, was inoculated intraperitoneally into 3-week-old male Sprague-Dawley rats at a single dose. The final inoculum was 2 ϫ 10 7 CFU/rat in 0.1 ml of phosphate-buffered saline (PBS). This resulted in polyclonal activation of lymphoid cells and nonfatal meningitis with high leukocyte counts and positive bacterial cultures in CSF.
Preparation of splenocytes. Rats were sacrificed at days 2, 3, 7, 9, 14, 30, and 37 p.i. (six Hib inoculated and four control rats at each time point). Spleens were dissected and crushed through a mesh network, followed by osmotic lysis of erythrocytes. Splenocytes were washed three times in tissue culture medium consisting of Iscove's modified Dulbecco's medium (Flow Laboratories, Irvine, United Kingdom). Cell viability always exceeded 95%, as evaluted by trypan blue staining. After being washed in PBS and counted in a Bürker chamber, 10 5 splenocytes were dried onto restricted areas of electrically charged glass slides (ProbeOn slides; Fisher Scientific, Pittsburgh, Pa.) and then stored in sealed boxes at Ϫ20°C. At day 3 p.i., splenocytes were used to enumerate IFN-␥-producing cells by immunospot assay (described below).
Detection of mRNA for cytokines by in situ hybridization. In situ hybridization was performed as described previously (7, 16) . Synthetic oligonucleotide probes (Scandinavian Gene Synthesis AB, Köping, Sweden) were labeled with 35 SdATP (New England Nuclear, Cambridge, Mass.) with terminal deoxynucleotidyl transferase (Amersham, Little Chalfont, United Kingdom). To increase the sensitivity of the method, a mixture of four different approximately 48-bp long oligonucleotide probes were used. The oligonucleotide sequences for IFN-␥ (8) and TNF-␣ (19) were obtained from GenBank, and probes were designed with MacVector software. Probes complementary to the antisense strands were used as control probes in parallel slides from each subject to ensure the specificity of the hybridization signals. These control probes produced a uniformly weak background signal without revealing any positive cells. Emulsion autoradiography was performed, and slides were coded. Cells expressing more than 20 grains over their cytoplasm were counted by dark-field microscopy with ϫ200 magnification. Accuracy was assessed at higher magnification, and light microscopy was performed at ϫ400. Results are expressed as numbers of labeled cells per 10 5 splenocytes.
Generation of monoclonal anticytokine Aabs. At day 7 p.i., suspended splenocytes from Hib-infected rats were hybridized with mouse Sp 2/0 cells as previously described (11) . Subcloning was performed once, and hybridoma supernatants with binding and neutralizing effects on biological assays for cytokines (see below) were selected and expanded. No clone has demonstrated reactivity to irrelevant proteins such as albumin.
Purification of Igs and preparation of Fab fragments. Immunoglobulins (Igs)
were purified on protein G columns from sera obtained at day 7 p.i. Fab fragments of purified Igs were prepared by papain digestion followed by removal of Fc fragments and any undigested antibodies on protein A.
ELISA for detection of anticytokine Aabs. At each time point, the Aab response was measured in sera of six Hib-inoculated and four control rats. The enzyme-linked immunosorbent assay (ELISA) for detection of anticytokine Aabs in sera was a modification of the assay previously described (3, 4) . Briefly, wells of polystyrene microtiter plates (Polysorp F96; Nunc, Glostrup, Denmark) were coated with 0.1 g of either recombinant IFN-␥ or TNF-␣ ( Fig. 1 and 2 ) (obtained from P. van der Meide, TNO Primare Centre, Rijswijk, Holland) per ml in carbonate-bicarbonate buffer (pH 9.6) overnight at room temperature. The following day, wells were washed twice with PBS containing 0.5% Tween 20 (PBST) and saturated with PBS containing 5% bovine serum albumin (BSA) for 1 h at 37°C. After being washed, controls and specimens were dispensed in the wells in 100-l amounts at a 1:200 dilution in PBST containing 2% BSA (PBSAT). After 1 h of incubation at 37°C and five washes, 100 l of biotinylated goat anti-rat IgG (Harlan, United Kingdom) diluted 1:2,000 in PBSAT was added. After another 1 h of incubation at 37°C and five washes, 100 l of avidin-biotin-alkaline phosphatase complex (ABC-AP) (Vector Laboratoties, Burlingame, Calif.) diluted 1:100 in PBS was added for 30 min. Unbound ABC-AP was removed by five consecutive washings with PBS, and 100 l of freshly prepared enzyme substrate solution was added per well. Absorbance was measured with a 405 Multiscan photometer (mcc/340; Labsystem, Helsinki, Finland). To detect possible noncytokine-specific reactions due to impurities of the cytokine antigen or to polyclonal B-cell activation, specimens were tested by ELISA with ovalbumin as an antigen on the soild phase by the same protocol and in parallel with the anticytokine Aab assay. The absorbance values obtained by testing the specimens against ovalbumin were very low, and even they were deducted from the absorbance value obtained by testing the specimens against the cytokines, the resulting absorbances being used for quantification of the anticytokine Aab levels in sera. Specimens from noninfected controls had very low levels of anticytokine Aabs. To further control the specificity of the Aabs, Fab fragments of purified serum Igs were examined in parallel studies and exhibited significant binding. Moreover, preabsorption of the sera with a recombinant cytokine inhibited the effects of binding to this particular cytokine, but not to any other in the ELISA system.
Single-cell assay for IFN-␥ secretion. The method described by Czerkinsky et al. (6) , as adapted to rat or mouse IFN-␥ (15), was used to detect IFN-␥ production by single secretory cells. In principle, nitrocellulose-bottom 96-well microtiter plates (Millipore, Bedford, Mass.) were coated overnight with 100-l aliquots of the mouse monoclonal antibody DB1, which is specific for IFN-␥ at a concentration of 15 g/ml (21). After repeated washings with PBS, 2% BSA was applied for 2 to 4 h, the plates were washed in PBS, and mononuclear cell suspensions were applied, followed by incubation overnight at 37°C in humidified atmosphere of 7% CO 2 . Cells were then removed by flicking the plate, followed by repeated washings in PBS. Polyclonal rabbit anti-rat IFN-␥ (21), diluted 1/1,000, was applied for 4 h. After the washing, biotinylated goat anti-rabbit IgG (Vector Laboratories) was applied for 4 h, followed by avidin-biotin-peroxidase complex (ABC Vectastain Elite kit; Vector Laboratories). Color development with 3-amino-9-ethylcarbazole and H 2 O 2 was performed (12) . Spots corresponding to cells that had secreted IFN-␥ were counted with a dissection microscope. In the blocking experiments, 10 l of serum, 5 g of Ig Fab fragments, or supernatant from the anti-IFN-␥ Aab-secreting clone was added to 200-l aliquots of cell suspension containing 10 6 splenocytes per well. Final concentrations of the serum were 1:20, 1:200, and 1:2,000. The Limulus amebocyte lyste COATEST endotoxin test (COATECH, Ljungby, Sweden) was used to detect endotoxin in the media and sera, and polymyxin B (Sigma) was used to absorb endotoxin when detected.
MHC expression on rat peritoneal macrophages. For assessment of major histocompatibility complex (MHC) antigen expression, a cell ELISA was used (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Blocking experiments were performed as described above.
Biological assay for TNF-␣. The thymocyte proliferation assay was used as previously described (14) . Blocking experiments were performed as outlined above.
RESULTS
Cytokine profiles during the course of experimental bacterial meningitis. The cytokines examined (IFN-␥ and TNF-␣) were selected in view of their potential immunoregulatory roles and their capability of inducing a whide range of effects on many cells. IFN-␥ mRNA expression was recorded at high levels in spleens with maximum induction at 2 days p.i., followed by a decline in both compartments by day 7. At day 14 p.i., no measurable IFN-␥ mRNA expression or secreting cells above control levels were detected. Splenocytes from noninoculated controls did not shown measurable levels or showed very low levels of IFN-␥. To correlate the mRNA expression to the actual production of the cytokine, the numbers of cells secreting IFN-␥ were enumerated with the immunospot assay. Coincident with the high levels of IFN-␥ mRNAexpressing splenocytes, large numbers of IFN-␥-secreting cells were registered on day 3 p.i. (Fig. 1A and B) . TNF-␣ mRNA expression was also recorded at high levels at day 2 p.i., gradually declining at days 3 and 7 p.i., and reached control levels by day 14 p.i. Control animals that received only PBS had very low levels of expression of TNF-␣ mRNA ( Fig. 2A) . Detection of anticytokine Aabs. Since the animal model used in this study was capable of downregulating the inflammatory mediators and controlling the infection, we examined the hypothesis that a mechanism in the form of an Aab is required for regulation of the immune response. Anticytokine Aabs of IgG subtypes were detected at high levels in sera of infected animals, while very low titers were recorded in both sera from Hib-infected rats reacting with ovalbumin and sera from noninoculated controls reacting with IFN-␥ or TNF-␣. Cytokine Aab levels for both IFN-␥ (Fig. 1A) and TNF-␣ ( Fig. 2A) were elevated from day 3 p.i., and peak levels were recorded at day 7 p.i. At day 30 p.i., very low levels were detected. At this time point, reinoculation of the rats was performed, and the Aabs were elevated again with kinetics and magnitude similar to those of the primary response. As confirmation of the specificity of these Aabs, Fab fragments of purified serum Igs exhibited a similar binding stringency to IFN-␥ and also inhibited IFN-␥ production by splenocytes. Furthermore, preincubation of the Aabs with IFN-␥ blocked their inhibitor effects on IFN-␥ production, but this was not the case when the Aabs were preincubated with TNF-␣ (Fig. 1B) . In similar experiments, Fab fragments of purified serum Igs bound to TNF-␣ (not shown).
Regulatory role of the anticytokine Aabs. To confirm an important regulatory role of these Aabs during the course of disease and their neutralizing effects on the cytokines produced, blocking experiments were performed with different dilutions of the sera obtained on day 7 p.i., Fab fragments of Igs purified from these sera, and supernatants from the cloned B cells producing Aabs to the selected cytokines. The sera, Fab fragments, and anti-IFN-␥ Aabs in the supernatant inhibited IFN-␥ production by splenocytes from infected rats in a dosedependent manner. Inhibition of the blocking effects after preincubation of the Fab fragments with 100 U of recombinant IFN-␥ per ml was noted. However, preabsorption of the sera at a dilution of 1:200 with 100 U of recombinant TNF-␣ per ml did not influence the inhibitor effects of the sera on IFN-␥ secretion (Fig. 1B) . In other experiments, IFN-␥-induced MHC antigen expressed by peritoneal macrophages (20) was similarly inhibited (Fig. 1C) . With the thymocyte proliferation method used as a functional assay for TNF-␣ (14), TNF-␣-induced thymocyte proliferation was also inhibited in a dosedependent manner by the sera and the anti-TNF-␣ Aab supernatant (Fig. 2B ).
DISCUSSION
Our observation that intraperitoneal inoculation of Hib to 3-week-old rats leads to polyclonal activation of immunocompetent cells and self-limiting meningitis gave us the impetus to investigate the mechanisms behind control of the infection. Cytokines are proteins that act as signals between the cells of the immune system. They elicit different activities on different cells with overlapping spectrums of action. They act in synergy or may exhibit antagonisms. The bacterial model used in this study displayed upregulation of most cytokines, which may negatively influence the outcome of a beneficial immune response required to clear the infection. However, this was not the case, since the animals successfully downregulated the elevated mediators and controlled the infection.
The data presented herein highlight a new pertinent and important immunoregulatory mechanism that prevents a hyperactivation state of mediators and allows facilities for desired specific responses. Antibodies directed against self cytokines were released synchronously in sera, leading to neutralization of excess cytokines and regulation of the immune response. These Aabs disappear after performing their task and before induction of idiotypic antibodies occur, since they remained at high levels for only 1 to 2 days and could reappear upon restimulation. The absence of Aabs to irrelevant proteins such as albumin in sera, binding of Aab Fab fragments to cytokines, and inhibition of biological effects by preincubation with recombinant cytokines suggest that they reflect specific responses rather than nonspecific polyclonal immune activation. This was further confirmed by the demonstration of an absence of crossreactivity between the antibodies measured, since preabsorption of the sera with TNF-␣ did not affect the binding activity to IFN-␥ and vice versa.
The regulatory mechanism presented here may suggest a role of maintained balance of autoimmunity in the control of cytokine responses and hence Hib infections. In support of this hypothesis, treatment with anti-TNF-␣ and anti-IL-␤ antibodies reduced meningeal inflammation and was protective in classical animal models of bacterial meningitis with intracisternal inoculation and fatal outcome (17) , suggesting a key role for intrathecally produced cytokines in the development of tissue damage in infectious meningitis. However, investigations of other animal models and inclusion of a different noxious antigen such as a viral challenge are currently ongoing in our laboratories in order to elucidate the significance of the Aabs in the course of the infection and/or the course of resolution of inflammation after infection is controlled. Anti-IFN-␥ antibodies in sera from human immunodeficiency virus-infected patients (4) and in African trypanosomiasis (3) have been previously reported. Relatively high concentrations of high-affinity IgG antibodies against IL-6 and IL-1␣ were also recorded in the circulation of healthy adults, suggesting a significant role of autoimmunity in the regulation of certain cytokines (10) . The regulatory roles of the Aabs detected in this study were confirmed by blocking and neutralizing experiments. The successful cloning of the B cells producing these Aabs will allow further studies of mechanisms of production and action. They should also be useful in immunological assays designed to study the production and roles of cytokines during courses of other immune systems challenges.
